Ex parte INBAE YOON - Page 4




          Appeal No. 96-2631                                                          
          Application No. 08/177,616                                                  


          positions articulated by the appellant and the examiner.  It is             
          our conclusion that Allen is insufficient to establish                      
          obviousness with respect to claims 1 through 27.  Accordingly, we           
          will not sustain the examiner's rejection of claims 1 through 27            
          under 35 U.S.C. § 103.  Our reasoning for this determination                
          follows.                                                                    


               Before addressing the examiner's rejection based upon prior            
          art, it is an essential prerequisite that the claimed subject               
          matter be fully understood.  Analysis of whether a claim is                 
          patentable over the prior art under 35 U.S.C. §§ 102 and 103                
          begins with a determination of the scope of the claim.  The                 
          properly interpreted claim must then be compared with the prior             
          art.  Claim interpretation must begin with the language of the              
          claim itself.  See Smithkline Diagnostics, Inc. v. Helena                   
          Laboratories Corp., 859 F.2d 878, 882, 8 USPQ2d 1468, 1472 (Fed.            
          Cir. 1988).  Furthermore, it is axiomatic that, in proceedings              
          before the PTO, claims in an application are to be given their              
          broadest reasonable interpretation consistent with the                      
          specification, and that claim language should be read in light of           
          the specification as it would be interpreted by one of ordinary             
          skill in the art.  In re Sneed, 710 F.2d 1544, 1548, 218 USPQ               

                                          4                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007